The shaking and racing heartbeat were less noticeable after I took it as prescribed. I still felt nervous mentally, so it helped the physical part rather than removing the anxiety.
Propranolol
Propranolol is a non-selective beta-blocker for people who need treatment for selected cardiovascular conditions, tremor, migraine prevention or physical anxiety symptoms. It blocks beta-1 and beta-2 receptors, reducing heart rate, tremor and some adrenaline-related blood-pressure responses. The dose is stated on the pack — follow the leaflet.
Description
Propranolol is a non-cardioselective beta-blocker used for selected cardiovascular, neurological and physical anxiety symptoms. The oral tablets reduce the effects of noradrenaline on the heart and blood vessels, helping control heart rate, tremor and some blood-pressure responses. The dose is stated on the pack — follow the leaflet.
Composition
Propranolol is the active medicine in the oral tablets described on this product page. The dose is stated on the pack — follow the leaflet. The tablet is intended for oral use.
Immediate-release propranolol reaches the bloodstream in a way that supports divided dosing when prescribed for regular cardiovascular treatment. Modified-release beta-blocker products use different release characteristics and should not be substituted tablet-for-tablet without a prescriber’s instruction.
A tablet’s strength does not determine the correct regimen by itself. Migraine prevention, angina, hypertension, tremor and physical anxiety symptoms can require different schedules. The same strength may therefore be used differently for different patients.
Dosage and usage
The product is supplied as oral tablets, with 28 tablets per pack. The dose is stated on the pack — follow the leaflet. The prescribed schedule can differ substantially between hypertension, angina, migraine prevention, tremor and anxiety symptoms.
- Take the tablet by mouth with water.
- Take it at the same times each day when used regularly.
- Swallow the tablet as prescribed rather than changing the dose to adjust the pulse yourself.
- For an occasional physical-anxiety indication, use it only according to the prescribed timing.
- If a dose is missed, take it when remembered unless the next dose is near.
- Do not double the next dose after a missed tablet.
- Do not stop regular treatment suddenly.
Abrupt withdrawal can produce rebound tachycardia, worsening angina and a rise in blood pressure. Patients with coronary artery disease face a greater risk from sudden discontinuation, so dose reduction should follow a planned schedule.
Food can affect absorption, and the relationship may differ between formulations. Taking regular tablets consistently in relation to meals reduces day-to-day variation. Do not crush or split a tablet unless the dispensing instructions specifically allow it.
One practical mistake is measuring benefit too early. A dose used before a presentation may reduce shaking within a few hours, while migraine prevention generally requires regular treatment over a longer period before its value can be judged.
How it works
Propranolol belongs to the beta-blocker class and blocks both beta-1 and beta-2 adrenergic receptors. It is a non-selective beta-adrenergic blocking agent, so its effects extend beyond the heart to the airways and peripheral blood vessels.
Beta receptors respond to catecholamines such as noradrenaline and adrenaline. When propranolol occupies these receptors, the heart beats more slowly and with less force. The kidneys also receive less beta-1 stimulation, which can reduce renin release and contribute to lower blood pressure. [1]
Receptor inhibition profile
Beta-1 receptor blockade mainly produces:
- A slower resting and exercise heart rate
- Reduced force of cardiac contraction
- Lower cardiac workload and oxygen demand
- Slower conduction through the atrioventricular node
- Reduced renin release from the kidneys
Beta-2 receptor blockade explains several additional effects. It can reduce tremor by limiting beta-2-mediated muscle activity, yet it can also narrow the airways in susceptible people. This non-cardioselective profile is the reason propranolol requires more caution in asthma and some forms of chronic obstructive airway disease than a cardioselective beta-blocker.
Propranolol is lipid-soluble and crosses the blood-brain barrier. That property may contribute to its usefulness for migraine prevention, essential tremor and some physical manifestations of anxiety. It does not remove anxious thoughts in the same way that a psychological treatment or an antidepressant may.
Indications
Propranolol 40 mg tablets may be prescribed for several conditions. The suitable dose and schedule depend on the indication, heart rate, blood pressure, age, liver function and other medicines.
| Clinical use | Main physiological target | Expected treatment goal |
|---|---|---|
| Hypertension | Heart rate, cardiac output and renin release | Lower blood pressure |
| Angina pectoris | Cardiac oxygen demand | Reduce exertional chest pain |
| Essential tremor | Beta-2-mediated muscle activity | Reduce shaking |
| Migraine prevention | Neural and vascular signalling | Reduce attack frequency |
| Physical anxiety symptoms | Adrenaline-related responses | Reduce palpitations, shaking and sweating |
Propranolol is also used in selected rhythm disorders, after a heart attack and for certain symptoms related to excessive thyroid hormone activity. Some uses, such as performance anxiety, are off-label and focus on sweating, tremor, a racing heart and a shaky voice rather than the emotional cause of anxiety.
The medicine is not a general treatment for every type of anxiety. It may help when physical adrenaline symptoms dominate, while persistent worry, obsessive thoughts or depressed mood require a different clinical approach.
The American Heart Association recognises beta-blockers as medicines with important cardiovascular roles, while migraine guidance places propranolol among preventive options for suitable patients. [2]
Comparison
Metoprolol is a cardioselective beta-blocker that acts mainly at beta-1 receptors at usual doses. Propranolol blocks beta-1 and beta-2 receptors, giving it a wider physiological effect.
| Feature | Propranolol | Metoprolol |
|---|---|---|
| Receptor profile | Non-selective beta-1 and beta-2 blockade | Predominantly beta-1 blockade at usual doses |
| Central nervous system entry | Lipid-soluble; enters the brain readily | Enters the brain, with a different pharmacological profile |
| Common clinical emphasis | Tremor, migraine prevention, selected anxiety symptoms and cardiovascular disease | Hypertension, angina, rate control and some heart-failure regimens |
Cardioselectivity is relative, not absolute. Higher doses of metoprolol can affect beta-2 receptors, while propranolol may be unsuitable for people with reactive airway disease. The choice depends on the clinical target rather than on a simple ranking between medicines.
For tremor or performance-related palpitations, propranolol may be selected because it reduces peripheral adrenergic symptoms. For a patient with airway disease who needs heart-rate control, a cardioselective option may be considered instead. Both medicines can cause bradycardia, fatigue, dizziness and exercise intolerance.
Contraindications
Propranolol should generally be avoided or used only under specialist direction in people with:
- Asthma or a history of significant bronchospasm
- Severe chronic obstructive airway disease with bronchial reactivity
- Marked bradycardia
- Second- or third-degree heart block without a pacemaker
- Sick sinus syndrome
- Cardiogenic shock
- Decompensated heart failure
- Severe peripheral arterial circulation problems
- A previous serious reaction to propranolol or another beta-blocker
Diabetes is not always an absolute contraindication, but extra monitoring may be needed because propranolol can mask tachycardia during hypoglycaemia. People with psoriasis, Raynaud-type symptoms, depression or liver impairment may also need an individual risk assessment.
Interacting medicines
| Medicine or class | Main concern | Clinical approach |
|---|---|---|
| Clonidine | Withdrawal can cause rebound hypertension; combined use can slow the heart | Never stop either medicine abruptly; supervised sequencing is required |
| Verapamil or diltiazem | Additive slowing of heart rate, conduction and contraction | Pulse, blood pressure and conduction require clinical monitoring |
| ACE inhibitors, alpha-blockers or other antihypertensives | Excessive blood-pressure reduction or dizziness | Review the full regimen and adjust gradually |
| Insulin and sulfonylureas | Masked symptoms of hypoglycaemia | Monitor glucose and recognise non-pulse warning signs |
| NSAIDs | May reduce the blood-pressure-lowering effect in some patients | Use the lowest suitable duration and monitor blood pressure |
| Digoxin or anti-arrhythmic medicines | Increased risk of bradycardia or conduction disturbance | Combination requires prescriber oversight |
Clonidine deserves special care. Stopping clonidine while continuing beta-blockade can worsen rebound hypertension, while stopping propranolol first may also require a carefully planned sequence. Calcium-channel blockers such as verapamil can produce additive negative inotropic effects, meaning the heart contracts more slowly and less forcefully.
Alcohol may increase dizziness or drowsiness. Some antidepressants and other medicines that affect liver enzymes can alter propranolol exposure. Provide a complete medicine list before treatment changes, including eye drops, inhalers and non-prescription pain medicines.
When this is not for you
Propranolol is not suitable for everyone. It is NOT for you if you have asthma, marked bradycardia, heart block without a pacemaker or a previous serious reaction to a beta-blocker. A prescriber must assess the heart rhythm, lung history, circulation, glucose control and current medicines before regular treatment.
Side effects
Propranolol can cause side effects because beta receptors are present in the heart, blood vessels, airways and skeletal muscle. The response depends on dose, baseline pulse, lung function and other medicines.
Common or clinically recognised effects include:
- Slow heart rate, known as bradycardia
- Cold hands or feet
- Tiredness and reduced exercise tolerance
- Dizziness, especially after standing
- Sleep disturbance or vivid dreams
- Drowsiness
- Nausea, abdominal discomfort or diarrhoea
- Reduced libido or erectile dysfunction
- Wheezing or breathing difficulty in susceptible people
Bradycardia results from slower impulse formation and reduced conduction through the heart. Dizziness may arise when the heart rate or blood pressure falls faster than the body can compensate. Gastrointestinal symptoms are often mild, though persistent diarrhoea or vomiting can affect hydration and blood pressure. Symptoms should be recorded alongside pulse and blood-pressure readings. Persistent or severe effects require clinical review.
Bronchoconstriction is a more serious concern because propranolol blocks beta-2 receptors in the airways. New wheezing, chest tightness or difficulty breathing requires urgent medical attention. The medicine can also mask warning signs of low blood glucose, especially a fast heartbeat, in people using insulin or sulfonylureas.
Sexual side effects are possible but do not affect everyone. A change in erectile function can result from lower sympathetic stimulation, reduced exercise tolerance, the underlying cardiovascular condition or another medicine.
Drowsiness can occur early in treatment. Until the individual response is clear, driving, cycling on busy roads and operating machinery require caution.
Common mistakes
Several mistakes reduce benefit or increase risk:
- Stopping regular treatment suddenly after feeling better
- Taking an extra tablet because the pulse feels fast
- Using propranolol for severe chest pain instead of seeking urgent care
- Forgetting to mention asthma or previous wheezing
- Combining it with verapamil, diltiazem or clonidine without review
- Assuming it treats anxious thoughts as well as physical symptoms
- Taking a missed dose together with the next scheduled dose
- Ignoring fainting, wheezing or severe weakness
- Failing to monitor glucose symptoms when using insulin
- Switching between release formulations without a new prescription
One detail patients often miss is that propranolol can make exercise feel harder because the heart cannot increase its rate normally. That effect is pharmacological, not proof of poor fitness.
Another is that cold fingers and toes can become more noticeable in winter or in people with peripheral circulation problems. Persistent colour change, pain or numbness warrants clinical review.
What doctors say
In clinical practice, doctors often assess three findings together: resting pulse, standing blood pressure and the symptom being treated. A lower pulse may show receptor blockade, but it does not prove that migraine, angina or tremor prevention is adequate.
A physician would usually set a practical treatment target. For migraine, that may mean fewer attacks over several weeks. For tremor, it may mean improved handwriting or steadier use of utensils. For performance anxiety, the relevant outcome may be less shaking during a specific event, while persistent worry remains unchanged.
Doctors also distinguish physical anxiety symptoms from panic disorder, depression and generalised anxiety. Propranolol can reduce sweating, tremor and palpitations, but it does not address every psychological feature of anxiety.
A useful clinical review includes the timing of symptoms, pulse readings, dizziness, sleep changes, exercise tolerance and any wheezing. These details help separate an expected effect from excessive beta-blockade.
Frequently asked questions
Does propranolol treat anxiety?
Propranolol can reduce physical symptoms such as tremor, sweating and palpitations, especially when they occur in predictable situations. It does not directly treat persistent worry, intrusive thoughts or depressed mood. Clinical guidance from the National Institute for Health and Care Excellence available in 2025 continues to distinguish physical symptom control from psychological treatment. The medicine may be used off-label when a clinician considers that pattern appropriate.
How quickly can propranolol affect physical symptoms?
The effect on heart rate and adrenaline-related symptoms may begin within a few hours of an oral dose, though timing varies with the individual and the indication. Migraine prevention requires regular use and a longer assessment period than occasional performance-anxiety treatment. Pharmacology references from the WHO in 2023 describe beta-blockade as a receptor effect rather than a treatment that instantly removes anxiety. A rapid pulse should not be treated with extra tablets unless that plan was prescribed.
Can propranolol be used for migraine prevention?
Propranolol is used as a preventive option for some people with recurrent migraine. The aim is to reduce attack frequency, severity or reliance on acute treatment, rather than to stop an attack immediately. The American Academy of Neurology and related migraine guidance available in 2024 place beta-blockers among preventive approaches with patient-selection requirements. Asthma, low pulse and low blood pressure can make it unsuitable.
Can propranolol be taken with asthma?
Propranolol can narrow the airways because it blocks beta-2 receptors. People with asthma or previous bronchospasm may experience wheezing or reduced response to some inhaled bronchodilators. SAHPRA safety information for beta-blocking medicines available in 2024 requires attention to bronchospasm risk and patient history. New breathing difficulty after a dose requires urgent medical assessment.
Does propranolol lower blood pressure?
Propranolol can lower blood pressure through reduced heart rate, reduced cardiac output and reduced renin release. The size of the effect depends on the starting blood pressure, dose and other antihypertensive medicines. The European Medicines Agency describes beta-blocker monitoring around pulse, blood pressure and conduction effects in its cardiovascular medicine information from 2022. Dizziness on standing can signal that the combined treatment is too strong.
What happens if propranolol is stopped suddenly?
Sudden withdrawal after regular use can produce rebound palpitations, increased blood pressure or worsening angina. The risk is higher in people with coronary artery disease or significant cardiovascular symptoms. FDA prescribing information from 2010 advises gradual reduction rather than abrupt discontinuation. A planned taper must account for the reason for treatment, current dose and duration of use.
Can propranolol cause a slow heartbeat?
Yes. Bradycardia is a direct result of beta-1 receptor blockade and slower cardiac conduction. A mild reduction may be expected, while fainting, confusion, severe weakness or a very slow pulse requires prompt assessment. South African clinical practice under SAHPRA oversight in 2024 uses pulse, blood-pressure and symptom review to judge tolerability. Do not change the dose independently in response to a home pulse reading.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Comparison
Compare all medications for HypertensionPropranolol: Reviews and Experiences
My readings improved over the first few weeks. I felt tired climbing stairs at first, and my clinician reviewed the dose rather than telling me to push through it.
After several weeks, the attacks were less frequent. The first days brought cold hands and mild dizziness, which settled when I stood up slowly.
Writing was steadier during meetings. I disliked the lower exercise tolerance and needed a review before continuing regular treatment.
Sources
- U.S. Food and Drug Administration (2010). Inderal (propranolol hydrochloride) prescribing information.
- American Academy of Neurology (2012). Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults.